Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2015 (← Previous) (Next →)
Filing Date: May 15, 2015
Total Value: $647M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RECEPTOS INC | 390,312 | $64.36M | 9.9% | $43.18 | — | COM | 756207106 |
| ALKS | ALKERMES PLC | 700,000 | $42.68M | 6.6% | $56.67 | +20.6% | SHS | G01767105 |
| PBYI | PUMA BIOTECHNOLOGY INC | 167,300 | $39.5M | 6.1% | $146.25 | +46.2% | COM | 74587V107 |
| EGRX | EAGLE PHARMACEUTICALS INC | 716,500 | $30.01M | 4.6% | $20.11 | +41.1% | COM | 269796108 |
| BMY | BRISTOL MYERS SQUIBB CO | 459,000 | $29.61M | 4.6% | $39.44 | +10.2% | COM | 110122108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 718,900 | $28.55M | 4.4% | $15.30 | +133.9% | COM | 64125C109 |
| — | PORTOLA PHARMACEUTICALS INC | 574,500 | $21.81M | 3.4% | $27.49 | — | COM | 737010108 |
| SRNE | SORRENTO THERAPEUTICS INC | 1,652,912 | $19.11M | 3.0% | $7.89 | +46.6% | COM NEW | 83587F202 |
| — | DYAX CORP | 1,138,900 | $19.08M | 2.9% | $7.54 | — | COM | 26746E103 |
| — | QUOTIENT LTD | 1,119,100 | $19.02M | 2.9% | $13.68 | — | SHS | G73268107 |
| HRTX | HERON THERAPEUTICS INC | 1,270,000 | $18.48M | 2.9% | $11.64 | -3.2% | COM | 427746102 |
| — | OVASCIENCE INC | 462,720 | $16.07M | 2.5% | $25.13 | — | COM | 69014Q101 |
| — | REGULUS THERAPEUTICS INC | 896,522 | $15.19M | 2.3% | $14.62 | — | COM | 75915K101 |
| — | ADVAXIS INC | 975,375 | $14.08M | 2.2% | $7.24 | — | COM NEW | 007624208 |
| ARDX | ARDELYX INC | 1,013,785 | $13.27M | 2.1% | $19.95 | -6.1% | COM | 039697107 |
| — | TESARO INC | 191,250 | $10.98M | 1.7% | $28.24 | — | COM | 881569107 |
| — | KERYX BIOPHARMACEUTICALS INC | 826,000 | $10.52M | 1.6% | $13.75 | — | COM | 492515101 |
| — | NOVAVAX INC | 1,238,300 | $10.24M | 1.6% | $4.95 | — | COM | 670002104 |
| DXCM | DEXCOM INC | 153,000 | $9.538M | 1.5% | $7.91 | +90.9% | COM | 252131107 |
| — | KARYOPHARM THERAPEUTICS INC | 300,987 | $9.213M | 1.4% | $33.09 | — | COM | 48576U106 |
| — | ALDER BIOPHARMACEUTICALS INC | 317,475 | $9.162M | 1.4% | $24.78 | — | COM | 014339105 |
| — | CHIMERIX INC | 229,500 | $8.65M | 1.3% | $27.07 | — | COM | 16934W106 |
| OMER | OMEROS CORP | 388,500 | $8.559M | 1.3% | $12.81 | +78.3% | COM | 682143102 |
| — | EPIRUS BIOPHARMACEUTICALS IN | 896,600 | $8.025M | 1.2% | $8.68 | — | COM | 29428P107 |
| — | PFENEX INC | 474,900 | $7.57M | 1.2% | $15.94 | — | COM | 717071104 |
| — | CHINA BIOLOGIC PRODS INC | 76,500 | $7.307M | 1.1% | $44.47 | — | COM | 16938C106 |
| — | AGENUS INC | 1,409,000 | $7.228M | 1.1% | $4.10 | — | COM NEW | 00847G705 |
| — | FORWARD PHARMA A/S | 255,000 | $7.222M | 1.1% | $23.92 | — | SPONSORED ADR | 34986J105 |
| SGMO | SANGAMO BIOSCIENCES INC | 442,000 | $6.931M | 1.1% | $17.13 | -9.6% | COM | 800677106 |
| CHRS | COHERUS BIOSCIENCES INC | 219,130 | $6.701M | 1.0% | $14.11 | +83.2% | COM | 19249H103 |
| — | ACCELERON PHARMA INC | 170,000 | $6.47M | 1.0% | $32.10 | — | COM | 00434H108 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 102,000 | $6.333M | 1.0% | $46.32 | +19.9% | COM | 90400D108 |
| — | CURIS INC | 2,632,000 | $6.317M | 1.0% | $2.28 | — | COM | 231269101 |
| — | ARRAY BIOPHARMA INC | 850,000 | $6.265M | 1.0% | $5.01 | — | COM | 04269X105 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 680,000 | $6.14M | 0.9% | $9.67 | +7.1% | COM | 09058V103 |
| — | RECRO PHARMA INC | 655,907 | $5.949M | 0.9% | $6.07 | — | COM | 75629F109 |
| — | APTOSE BIOSCIENCES INC | 1,081,867 | $5.825M | 0.9% | $5.91 | — | COM NEW | 03835T200 |
| — | KITE PHARMA INC | 100,000 | $5.768M | 0.9% | $46.23 | — | COM | 49803L109 |
| — | MINERVA NEUROSCIENCES INC | 1,145,043 | $5.725M | 0.9% | $5.16 | — | COM | 603380106 |
| — | LION BIOTECHNOLOGIES INC | 424,815 | $5.145M | 0.8% | $12.11 | — | COM | 53619R102 |
| — | EPIZYME INC | 266,250 | $5M | 0.8% | $18.78 | — | COM | 29428V104 |
| — | LIPOCINE INC NEW | 666,666 | $4.6M | 0.7% | $6.90 | — | COM | 53630X104 |
| — | NEKTAR THERAPEUTICS | 397,500 | $4.373M | 0.7% | $12.07 | — | COM | 640268108 |
| — | SYNAGEVA BIOPHARMA CORP | 42,500 | $4.145M | 0.6% | $68.78 | — | COM | 87159A103 |
| — | DICERNA PHARMACEUTICALS INC | 170,000 | $4.085M | 0.6% | $16.47 | — | COM | 253031108 |
| — | GLYCOMIMETICS INC | 458,955 | $3.819M | 0.6% | $16.33 | — | COM | 38000Q102 |
| — | GENVEC INC | 1,262,835 | $3.725M | 0.6% | $2.65 | — | COM NEW | 37246C307 |
| — | ROCKWELL MED INC | 340,000 | $3.716M | 0.6% | $12.66 | — | COM | 774374102 |
| — | CERULEAN PHARMA INC | 401,354 | $3.616M | 0.6% | $5.80 | — | NEW | 15708Q105 |
| — | ACELRX PHARMACEUTICALS INC | 850,000 | $3.281M | 0.5% | $9.56 | — | COM | 00444T100 |
| — | VERSARTIS INC | 170,000 | $3.123M | 0.5% | $28.04 | — | COM | 92529L102 |
| — | NANOSTRING TECHNOLOGIES INC | 275,000 | $2.802M | 0.4% | $20.65 | — | COM | 63009R109 |
| — | DERMIRA INC | 170,000 | $2.61M | 0.4% | $18.11 | — | COM | 24983L104 |
| — | IMMUNE DESIGN CORP | 119,000 | $2.512M | 0.4% | $17.66 | — | COM | 45252L103 |
| — | KINDRED BIOSCIENCES INC | 328,497 | $2.345M | 0.4% | $11.93 | — | COM | 494577109 |
| — | AQUINOX PHARMACEUTICALS INC | 279,900 | $2.301M | 0.4% | $12.15 | — | COM | 03842B101 |
| — | AGILE THERAPEUTICS INC | 182,053 | $1.688M | 0.3% | $8.82 | — | COM | 00847L100 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $1.648M | 0.3% | $2.22 | — | COM NEW | 15117F203 |
| — | BELLICUM PHARMACEUTICALS INC | 51,000 | $1.182M | 0.2% | $23.03 | — | COM | 079481107 |
| AKBA | AKEBIA THERAPEUTICS INC | 100,300 | $1.114M | 0.2% | $24.08 | -55.8% | COM | 00972D105 |
| ASND | ASCENDIS PHARMA A S | 61,500 | $1.067M | 0.2% | $17.35 | — | SPONSORED ADR | 04351P101 |
| VCYT | VERACYTE INC | 135,190 | $984K | 0.2% | $7.90 | +3.6% | COM | 92337F107 |
| GALT | GALECTIN THERAPEUTICS INC | 286,200 | $959K | 0.1% | $13.23 | -73.0% | COM NEW | 363225202 |
| CLLS | CELLECTIS S A | 25,000 | $865K | 0.1% | $34.60 | — | SPONSORED ADS | 15117K103 |
| — | SCYNEXIS INC | 99,366 | $825K | 0.1% | $8.02 | — | COM | 811292101 |
| — | APPLIED GENETIC TECHNOL CORP | 26,010 | $520K | 0.1% | $23.10 | — | COM | 03820J100 |
| PTCT | PTC THERAPEUTICS INC | 8,500 | $517K | 0.1% | $26.39 | +131.2% | COM | 69366J200 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $413K | 0.1% | $0.60 | — | *W EXP 08/19/201 | 15117F112 |
| — | NEVRO CORP | 8,500 | $407K | 0.1% | $38.70 | — | COM | 64157F103 |
| — | CELSUS THERAPEUTICS PLC | 286,508 | $218K | 0.0% | $5.99 | — | SPONSORED ADR NE | 15119A202 |
| — | SAGE THERAPEUTICS INC | 850 | $43,000 | 0.0% | $31.50 | — | COM | 78667J108 |